Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk - Reuters

Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk  ReutersF.D.A. Approves New Eli Lilly Obesity Pill, Foundayo  nytimes.comFDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions  Eli LillyLilly’s Obesity Pill Gets US Approval in Challenge to Novo  Bloomberg.comAnother GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used  CNN